Collectively, the results of the present study and those obtained in other studies [16], [25], [28] fully support that the ectopic expression of miR-122 in liver cancer cells triggers MET that may contribute to the inhibition of motility and invasion of cancer cells. The gene discussed is MET; the disease is cancer.